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Differentiation is a key cellular process in normal tissue development that is significantly
altered in cancer. Although molecular signatures characterising pluripotency and multipo-
tency exist, there is, as yet, no single quantitative mark of a cellular sample’s position in the
global differentiation hierarchy. Here we adopt a systems view and consider the sample’s
network entropy, a measure of signaling pathway promiscuity, computable from a sample’s
genome-wide expression profile. We demonstrate that network entropy provides a quantita-
tive, in-silico, readout of the average undifferentiated state of the profiled cells, recapitulating
the known hierarchy of pluripotent, multipotent and differentiated cell types. Network en-
tropy further exhibits dynamic changes in time course differentiation data, and in line with a
sample’s differentiation stage. In disease, network entropy predicts a higher level of cellular
plasticity in cancer stem cell populations compared to ordinary cancer cells. Importantly,
network entropy also allows identification of key differentiation pathways. Our results are
consistent with the view that pluripotency is a statistical property defined at the cellular pop-
ulation level, correlating with intra-sample heterogeneity, and driven by the degree of signal-
ing promiscuity in cells. In summary, network entropy provides a quantitative measure of a
cell’s undifferentiated state, defining its elevation in Waddington’s landscape.
Introduction
The observed diversity of mature cells and human tissues arises as a result of a complex, intri-
cate program of cellular differentiation, ultimately originating from (pluripotent) embryonic stem
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cells 1. Although systems biology principles underpinning the transitions between specific cellular
states, such as pluripotency and progenitor states, are in the process of being elucidated 2–5, much
remains to be learned. In the case of hematopoiesis, one of the best understood developmental sys-
tems, the full repertoire of transcription factors and signaling pathways dictating cell-fate is still
unknown 5–9. Other studies have focused on characterising the pluripotent and progenitor states in
terms of genome-wide gene expression 10–15, DNA methylation and chromatin state profiles 16–20.
Although these molecular signatures can discriminate cells of specific differentiation stages from
each other, there is, as yet, no single quantitative measure that can correctly place a sample within
the global differentiation hierarchy. Rephrased in the context of Waddington’s differentiation land-
scape 21, we do not yet have a molecular measure that can represent the energy potential, i.e. the
elevation, in Waddington’s landscape.
Recently, it has been proposed that pluripotency, and more generally, the undifferentiated state, is
an emergent statistical property of a population of cells 22–24, not well-defined at the single-cell
level. Specifically, it has been argued that high cellular diversity underpins the pluripotent or mul-
tipotent capacity of stem cell populations, with differentiated cell populations representing a more
uniform synchronised state 22. Motivated by this, we here explore a system’s property of a cellular
sample, called network entropy, in the context of cellular differentiation. At the single-cell level
network entropy can be thought of as an approximate measure of signaling pathway promiscuity
22, 25–27
. Thus, a highly undifferentiated cell, such as a pluripotent stem cell, would have a high
network entropy since it must maintain the option to initiate the activation of a wide number of
different signaling pathways associated with commitment to diverse cell fates 6. In contrast, a ter-
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minally differentiated cell would have a low network entropy, since it must maintain activation of
a few pathways specific to their fate. At the population level, high network entropy would thus
imply increased cellular heterogeneity, since the increased signaling promiscuity results in an in-
creased stochasticity across single cells. Thus, we posited that network entropy would provide a
direct molecular correlate of the undifferentiated state of a cellular sample, allowing us to place an
arbitrary sample at its appropriate elevation in Waddington’s landscape.
To test our hypothesis, we here compute sample-specific network entropies for a large number of
gene expression data sets relevant to cellular differentiation, reprogramming and cancer, encom-
passing over 800 samples, including cell-lines and primary tissue. Our main key findings are: (i)
network entropy is a highly accurate discriminator of pluripotent and non-pluripotent cell-types,
(ii) it can further discriminate cellular states of varying degrees of multipotency within distinct
lineages, (iii) it provides a more robust and general measure of a cell’s position in the global differ-
entiation hierarchy than gene expression signatures, and does so independently of cell proliferation,
and (iv) it predicts a higher cellular heterogeneity in cancer stem cells compared to ordinary cancer
cells.
Results
Construction and rationale of network entropy To compute network entropy requires estima-
tion of the signaling/interaction probabilities of proteins in a given sample. Thus, we integrated
the gene expression profile of a given sample with a comprehensive protein interaction signaling
network (PIN) (see SI ,28), using the mass-action principle to construct a sample-specific stochastic
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matrix pij where i and j label two distinct genes. The stochastic matrix provides a rough proxy
for the interaction probabilities present in the given sample and its construction is based on the
assumption that two genes known to interact at the protein level will have a greater interaction
probability when they are both highly expressed (see SI ). From the stochastic matrix, the network
entropy can be calculated as the entropy rate 29, 30
SR =
∑
i
piiSi (1)
where Si is the local entropy of node (gene/protein) i and where pii is the i’th element of the
stationary distribution of pij (i.e. pip = pi, see Methods, SI ). Thus, the entropy rate gives a steady-
state average measure of the uncertainty (or promiscuity) in signaling information flow over the
network. To facilitate comparison of entropy rates obtained from samples profiled on different
expression arrays, values were always normalised to the maximum possible entropy rate of a given
integrated network (SI , fig.S1).
We posited that the entropy rate of a sample (e.g. a cell-line), as computed above, would capture
the average level of signaling pathway promiscuity and hence of the cellular heterogeneity in the
sample. Under this model, highly undifferentiated and plastic cells, such as stem cells, would be
characterised by a state of high network entropy, allowing them the option to differentiate into di-
verse cell lineages (Fig.1A). Similarly, since differentiation implicates activation of specific molec-
ular signaling pathways, this activation would lead to a reduction in the uncertainty/promiscuity of
information flow, i.e. a low entropy state (Fig.1A).
As a proof of concept that the entropy rate does indeed measure the level of signaling promis-
cuity we first devised a simulation model (SI ). We compared the entropy rate of our PIN with
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weights defined by a uniform stochastic matrix (i.e. one with pij ∝ 1/ki where ki is the degree
of node i) representing a promiscuous poised state, to the entropy rate obtained by randomly acti-
vating individual genes and specific signal transduction pathways in the network (SI , Fig.1B). In
the case where individual genes were activated, this led, in approximately 70% of perturbations, to
a reduction in the global entropy rate (Binomial P < 0.001, Fig.1B). However, in the case where
whole signaling pathways were activated, the reduction in the entropy rate was observed in 85%
of cases (Binomial P < 10−10, Fig.1B), consistent with a substantially lower uncertainty in the
information flow.
Network entropy quantifies the level of multipotency Based on the simulation results, we
sought to determine if network entropy could discriminate biological samples that differ in terms
of their signaling promiscuity. Thus, we computed the network entropy rate of samples in the
“stem cell matrix” (SCM), a compendium of over 219 samples (mostly cell-lines), all profiled
with the same Illumina arrays, 59 of which were deemed pluripotent, with the rest (160) deemed
non-pluripotent 11. We observed that network entropy was significantly higher in the cell-lines
deemed pluripotent (P < 10−10, Fig.2A). To provide an independent benchmark we also com-
puted a t-test based pluripotency score (TPSC, SI ), constructed from an independent 19-gene
pluripotency expression signature, containing important pluripotency markers such as NANOG
and LIN28A 12. The TPSC pluripotency score was also significantly higher in the pluripotent cell
lines (SI , fig.S2), and both measures were significantly correlated, confirming that network en-
tropy is indeed a marker of pluripotency (Fig.2B). In an independently generated data set profiling
107 human embryonic and 52 induced pluripotent stem cell lines, as well as 32 differentiated tissue
6
samples 31, the entropy rate achieved 100% accuracy in discriminating pluripotent from differen-
tiated samples (Figs.2C-D). Crucially, all these results were independent of cell proliferation, as
we verified by removing cell proliferation and cycling genes 32 from the network (see SI , figs.S3-
S4). Furthermore, passage number and sex did not have noticeable effects on the entropy rate as
assessed in 107 human embyronic stem cell (hESC) lines (SI , fig.S5). Consistent with network
entropy being a marker of pluripotency we observed that induced pluripotent stem cell samples
exhibited high entropy values, similar to that of hESCs, and significantly higher than that of their
parental differentiated cells (P < 0.0001, SI , figs.S6-S7).
Next, we compared the network entropy of hESCs to that of committed but multipotent cell
types, including neural stem cells (NSCs), hematopoietic stem cells (HSCs) and mesenchymal
stem cells (MSCs). Confirming our hypothesis, all of these stem cell types exhibited entropies
which were lower than that of hESCs/iPSCs, but higher than their differentiated progeny (Fig.3A,
SI , S8-S9). Thus, network entropy can discriminate cells within a lineage according to their
differentiation status. To test this further, in a combined haematological data set 33, encompass-
ing a number of different blood cell types including differentiated types (e.g. monocytes), and
less differentiated ones (e.g. CD34+ HSCs and erythroblasts/megakaryocytes), network entropy
recapitulated a differentiation hierarchy consistent with prior knowledge 34, 35 (see SI , fig.S10).
Importantly, we observed that network entropy was a relatively robust measure, being fairly in-
sensitive to the normalisation or platform used (SI , figs.S8-S11), although in the case of MSCs
biological variations were evident (SI , figs.S8) 36, 37.
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Network entropy is reduced during differentiation If network entropy is a general measure of
the undifferentiated state of cells, it ought to exhibit dynamic changes in time course differenti-
ation data. To this end, we considered expression data of differentiated retinal pigment epithe-
lial cells, which were induced to de-differentiate, followed by a period of re-differentiation (SI ).
Remarkably, network entropy increased upon de-differentiation, reaching a maximum, with val-
ues subsequently dropping upon re-differentiation (Fig.3B). As another example, we considered
a time course data set consisting of human promyelocytic leukemia progenitor (HL60) cells, dif-
ferentiating into neutrophils 38. There were two separate time courses, using distinct stimuli to
induce differentiation of HL60 cells. In both cases, network entropy was significantly reduced
with time (ATRA stimulus, R2 = 0.96, P < 10−8, Fig.3B). Once again, these dynamic changes
were independent of cell-proliferation (SI , fig.S12).
Network entropy discriminates cancer stem cells, cancer and normal cells Differentiation is
a key distinctive feature of cancer and normal cells, with cancer representing a less differentiated
and more heterogeneous state. Confirming this, network entropy was consistently higher in cancer
tissue compared to normal cells, across four different tissue types, with cancer cell-lines exhibiting
even higher values (Fig.4A). We further analysed an expression data set profiling putative cancer
stem cells (CSCs) and their parental cancers across a number of different tissues 39. This showed
that CSCs exhibited a marginally higher network entropy than their non-stem like counterparts,
consistent with the view that CSCs retain a higher level of plasticity (Fig.4B).
Interestingly, comparing the network entropy of hESCs to teratocarcinomas and germ cell tumours
(all from the SCM and all deemed pluripotent), revealed marginally higher values in the hESCs
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(SI , fig.S13). This pattern of higher network entropy in normal stem cells was also seen in the non
pluripotent context: for instance, the network entropy of HSCs and NSCs was, in general, higher
than that of leukemic stem and glioma stem cells, respectively (SI , fig.S13-S14). Thus, while
CSCs and ordinary cancer cells exhibit significantly increased cellular heterogeneity compared to
normal differentiated tissue, CSCs do not appear to exhibit higher values relative to their normal
stem cell counterparts, and even appear to show reduced levels of entropy compared to normal
stem cells.
Dynamic changes in local network entropy identifies key differentiation genes and pathways
To demonstrate that the dynamic changes in entropy can be related to changes in activation of
specific pathways, we considered, as a proof of principle, the case of Notch-signaling. Notch sig-
naling is inactive yet inducible in the pluripotent state, with activation normally associated with
differentiation 40–45. Thus, essential components of the Notch signaling pathway should exhibit a
lower network entropy in the non-pluripotent state. Using data from the stem cell matrix 11, we
were able to confirm this for 12 of the 13 Notch pathway genes (SI , figs.S15-S16). To confirm
the statistical significance of this, in none of 10000 random selections of 13 genes from the PIN
did we observe the same level of consistency and statistical significance as for the Notch pathway
genes (P < 0.0001), indicating that reduced entropy of the Notch pathway is a key feature of the
non-pluripotent state (SI , fig.S17). It is also important to demonstrate that the interactors driving
the lower entropy of Notch genes are other Notch-pathway genes. For many Notch genes (e.g.
NOTCH2, NOTCH3, DLL1, JAG1, PSENEN, APH1A, APH1B) this was indeed the case, despite
the fact that there were also many non-Notch pathway interactors present (SI , figs.S16,S18).
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To further test the added value of local network entropy, we revisited the HL60 to neutrophil
time course data. Using linear regressions we identified the genes showing the most significant de-
creases and increases in network entropy. Ranking genes according to those showing the largest re-
ductions in network entropy and performing a subsequent Gene Set Enrichment Analysis (GSEA),
we identified JAK-STAT signalling as one of the key pathways (SI , fig.S19-S20). The involve-
ment of this pathway is heavily supported by previous studies 46–49. Attesting to the statistical
significance of the JAK-STAT pathway, computing entropies after randomly permuting the gene
expression profiles over the nodes in the network led to no significantly enriched biological terms
(adjusted P-values > 0.05). This is an important result because it shows that the dynamic network
entropy changes inferred from the integrated PIN are indeed targeting specific signaling path-
ways. Finally, using non-network based approaches did not identify the JAK-STAT pathway (SI ,
fig.S19).
Discussion
Here we have taken a systems analysis view of cellular differentiation, proposing the concept that
network entropy is inversely correlated with the differentiation status of a sample. By computing
the network entropy of over 800 samples, encompassing cell types from many diverse cell-lineages
and differentiation stages, and profiled using a variety of different microarray platforms, we have
demonstrated that entropy provides a near absolute quantification measure of the undifferentiated
state of any given sample.
In the context of normal physiology, hESCs and other pluripotent cell types were correctly pre-
10
dicted to exhibit the highest levels of network entropy, followed by multipotent stem cells (e.g.
NSC/HSC/MSC), with terminally differentiated cells exhibiting significantly lower entropy (Fig.5).
In the context of cancer, CSCs exhibited higher levels of cellular entropy than ordinary cancer cells,
although this difference appears substantially reduced in comparison to what is observed between
normal stem cells and their differentiated progeny (Fig.5). Cancer cell lines exhibited a higher en-
tropy than primary cancers, with cancer tissue possessing higher values than normal tissue (Fig.5).
All these findings are consistent with network entropy being a direct measure of the average
intra-sample cellular heterogeneity, supporting the view that cellular states such as pluripotency
are a statistical property of a cell population 6, 22. Indeed, although we have not analysed genome-
wide single-cell expression data, it is highly plausible that the degree of cellular heterogeneity is
determined by the level of signaling promiscuity, and hence stochasticity, in single cells 6, 22. The
observation that cancer stem cells exhibit a high but marginally lower network entropy than their
normal stem cell counterparts is also consistent with the view that CSCs must be characterised
by oncogenic pathway dependencies, which, as shown in a previous study, lead to a lowering of
network entropy 26. Local entropy analyses aimed at identifying the specific oncogenic pathways
driving the lower entropy in CSCs could thus offer novel therapeutic opportunities 26.
It is important to stress again that network entropy provides a very general system’s measure of
the undifferentiated state of a sample. In this regard, we remark that reported pluripotency ex-
pression signatures 12, 15, which lack a systems-level interpretation and understanding, could only
consistently discriminate pluripotent from non-pluripotent cell types, but generally failed to dis-
criminate cell types located further down the differentiation hierarchy, irrespective of normal or
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cancer physiology (SI , figs.S21-S27). Thus, the fact that network entropy provides a more refined
classification of the distinct cell types across the global differentiation hierarchy, and that it did so
independently of cell-proliferation indices, attests to the biological importance of this measure and
of the statistical mechanical framework on which it is based.
Although we observed some variation in entropy rates between studies profiling the same cell-
types using the same technology, it is nevertheless also important to note that these variations were
in general small and that network entropy provided a relatively robust measure of the undiffer-
entiated cellular state: for instance, hESCs always showed the highest levels of network entropy,
irrespective of study or platform. This robustness stems from two key features. First, network
entropy is a self-calibrating measure, as it is constructed by taking ratios of gene expression in-
tensity values. This makes it a dimensionless quantity and fairly insensitive to the microarray or
normalisation method used, unlike the scores derived from pluripotency signatures which showed
significant variations between studies (see SI , fig.S28). Second, network entropy is not affected by
overfitting since it is a quantity which does not depend on feature selection. Thus, unlike pluripo-
tency expression signatures 12, 14, 15, network entropy does not depend on tunable parameters. It
follows that network entropy could provide a simple, general and robust quantitative test for as-
sessing the pluripotency or multipotency of a cellular sample. For instance, it could be used to
assess the quality of iPSCs in reprogramming experiments or even to identify mislabeled samples.
Since a sample’s network entropy is computed from integration of its genome-wide expression
profile with a protein interaction network, it is important to also comment on the robustness of
the results in relation to the network, and more importantly on the number of genes that are mea-
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sured. Considering the HL60 differentiation time course data set as a test case, we observed that
randomly subsampling from the underlying integrated network and recomputing the entropy rates
for the resulting maximally connected components, still resulted in significant decreases of the en-
tropy rate with differentiation stage, as long as we subsample at least 40% of genes in the network
(SI, fig.S29). That the association between network entropy and differentiation stage is robust to
subsampling indicates that the dynamic changes in entropy are driven by a subtle interplay between
the gene expression changes and the topological properties of the nodes exhibiting these changes.
We leave investigation of this and other aspects to a future study.
In summary, we have proposed a relatively simple, computable, systems property of a genome-
wide expression profile, called network entropy, which provides an estimate of signaling promiscu-
ity and cellular heterogeneity, and which correlates with the undifferentiated state of cells. Network
entropy may thus serve as a quantitative in-silico proxy for a sample’s differentiation potential in
Waddington’s epigenetic landscape.
Methods
Full details of the data sets, interaction network and all statistical methods used are provided in SI.
Below, we give a brief sketch of how network entropy is calculated.
Construction of the sample specific stochastic matrix and network entropy rate The sample
specific stochastic matrix is estimated by integrating the gene expression profile of the sample with
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a comprehensive protein interaction network. Specifically, we invoke the mass action principle: let
Ei denote the normalised expression level of gene i in a given sample. For a given neighbour
j ∈ N(i) (where N(i) labels the neighbours of i in the PIN), the mass-action principle states that
the probability of interaction with i is approximated by the product EiEj . Normalising this to
ensure that ∑j pij = 1, we get
pij =
Ejs∑
k∈N(i)Eks
∀j ∈ N(i) (2)
Clearly, if j /∈ N(i), then pij = 0. This then defines a sample-specific stochastic matrix. From this
stochastic matrix one can then construct a local network entropy for each gene i in the PIN, as
Si = −
∑
j∈N(i)
pij log pij (3)
which reflects the level of uncertainty or promiscuity in the local interaction probabilities around
gene i. We note that the above expression for the local entropy is not normalised so that the
maximum possible entropy depends on the degree (ki) of the node i. In fact, maxSi = log ki.
Thus, it is convenient to also define a normalised local entropy as (see 25),
S˜i = −
1
log ki
∑
j∈N(i)
pij log pij (4)
We stress again that this local network entropy can be computed for each gene i in each given
sample. When defining a global network entropy (i.e. for the whole network) one can, in prin-
ciple, consider the average of these normalised local entropies. This average however is a non-
equilibrium entropy 26, in contrast to the global entropy rate, SR, which is defined in terms of the
stationary distribution, pi, of the stochastic matrix p, i.e. through pip = pi. Specifically, the global
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entropy rate, SR, is defined by 29, 30
SR =
∑
i
piiSi (5)
where Si are the unnormalised local entropies. We note that the network entropy rate is bounded
between 0 and a positive maximum value that depends only on the adjacency matrix of the network
50
. Indeed, it can be shown that the maximum possible entropy rate is attained by a stochastic
matrix, pij , defined by pij = Aijvj/λvi, where Aij is the adjacency matrix (i.e. unweighted)
of the PIN, and v and λ are the dominant eigenvector and eigenvalue of this adjacency matrix,
respectively. The maximum attainable entropy rate, MR, will thus depend on the specifics of the
network, including total number of genes, edges and topology. Thus, to facilitate comparison
between networks, the network entropy rate, SR, can be scaled relative to the maximum attainable
value in that given network, S˜R ≡ SR/MR, so that S˜R is always bounded between 0 and 1. In this
work, all reported entropy rates have been normalised in this way.
We note that computation of the entropy rate is computationally intensive as it requires estimation
of the stationary distribution of a large stochastic matrix. For a connected network of size 8290
nodes, computation of a sample’s entropy rate takes ∼ 10 minutes on a Dell Precision T5400
workstation. R-scripts performing the computations are freely available on request.
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Figure 1: Network entropy as the energy potential in Waddington’s landscape: A) Illustration
of network entropy’s role in cellular differentiation. The z-axis represents the network entropy
rate (SR) of a cell, which is a measure of the promiscuity/redundancy in the signaling patterns
within the cell. The two-dimensional plane spanned by the x-and-y axis represents gene expression
state/phase space. B) Simulation of pathway activation in a realistic protein interaction network
(only a small subnetwork is shown). In the left, edge weights are defined equally, so that the
random walk on the network is unbiased. On the right, a specific pathway is activated by increasing
the relative weights of edges connecting the genes in the pathway (shown in dark red). Lower
panel compares the entropy rate (SR) of the unbiased state, representing a highly promiscuous
poised cellular state (magenta diamond), to the entropy rates obtained by separately activating
each individual gene in the network (> 1000 perturbations, “Commt(Pert.)”), and to the entropy
rates obtained by activating whole signal transduction pathways (100 pathways, “Commt.(Path)”).
Binomial test P-values are given.
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Figure 2: Network entropy correlates with pluripotency: A) Normalised entropy rates
(SR/maxSR, y-axis) between the 59 pluripotent and 160 non-pluripotent cell-lines from the SCM
compendium (219 samples). P-value is from a Wilcoxon rank sum test. B) Scatterplot of the en-
tropy rate vs pluripotency score, where values for replicates of each cell type have been averaged.
Linear regression P-value and R2 value are given. C) Normalised entropy rates (SR/maxSR, y-
axis) between the 159 pluripotent and 32 differentiated samples from the SCM2. P-value is from a
Wilcoxon rank sum test. D) Corresponding ROC curve plus AUC of network entropy discriminat-
ing pluripotent from differentiated cells.
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Figure 3: Network entropy marks differentiation potential: A) Multi-lineage analysis: Left
panel: Comparison of normalised network entropy values of hESCs, hematopoietic stem cells
(HSCs), T & B-cell lymphocytes plus natural killer cells (LYMPH/NKC), and monocytes plus
neutrophils (MC/PMN). Middle panel: Comparison of normalised network entropy values of
hESCs, mesenchyma stem cells (MSCs) and differentiated osteoblasts (OST) and chondrocytes
(CHO). Right panel: Comparison of normalised network entropy values of hESCs, neural stem
cells (NSCs) derived from the hESCs, fetal neural stem cells (FNSC) and primary astrocytes (AC),
as derived from the SCM compendium (Illumina arrays). Wilcoxon rank sum test P-values be-
tween consecutive groups in the differentiation hierarchy are given. B) Dynamic changes in net-
work entropy: Left panel: Network entropy changes in a time course de-differentiation and re-
differentiation experiment of retinal pigment epithelium (RPE), with cell density indicating the ini-
tial plating density of RPE cells. Right panels: Network entropy rate (SR/maxSR, y-axis) changes
of HL60 leukemic progenitor cells against time from initial stimulus with either ATRA or DMSO.
The data points on the left indicate the less differentiated HL60 cells, whereas the ones on the far
right represent differentiated neutrophils. We provide the R2 values and associated P-values from
a linear regression.
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Figure 4: Network entropy discriminates cancer stem cells, cancer and normal tissue: A)
Comparison of normalised entropy rates (SR/maxSR) between normal and cancer tissue, as well
as cancer cell lines, across four different tissue types, as indicated. B) Comparison of normalised
entropy rates between putative cancer stem cells (CSC) and their parental tumour cell lines (PTC)
for five different tissue types. Combined Fisher t-test P-value is given.
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Figure 5: Network entropy rates between major cell types in normal and cancer physiology:
Network entropy correlates with pluripotency and anticorrelates with the differentiation stage of
cells. hESC: human embryonic stem cell, iPSC: induced pluripotent stem cell, MSC: mesenchymal
stem cell, HSC: hematopoietic stem cell, NSC: neural stem cell, CSC: cancer stem cell.
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